文献速递主动脉疾病外周动脉疾病

累及髂分叉的腹主动脉瘤开放与腔内修复结局比较

Outcomes of Open vs Endovascular Repair of Abdominal Aortic Aneurysm Involving the Iliac Bifurcation.
PubMed 文献 · Ann Vasc Surg · 2026-10-14

基于SVS VQI数据库的多中心真实世界研究,纳入7535例累及髂分叉的腹主动脉瘤修复患者,EVAR组5742例(76.2%),OAR组1793例(23.8%)。IPWR模型显示EVAR组院内死亡、30天死亡、MACE的OR均显著低于OAR,1年生存率显著更高。

要点

  • EVAR组院内死亡OR 0.25、30天死亡OR 0.31、MACE OR 0.24,均显著低于OAR。
  • EVAR组1年生存率显著高于OAR(HR 0.61,95%CI 0.50-0.76)。
  • 解剖适合的患者,EVAR可作为累及髂分叉主髂动脉瘤的首选修复方式。

核心结论

  • 在真实世界多中心研究中,累及髂分叉的腹主动脉瘤行EVAR较OAR的院内死亡、30天死亡、MACE风险更低,1年生存率更高。

研究设计与样本

  • 回顾性多中心队列研究,查询SVS VQI数据库,纳入7535例累及髂分叉的腹主动脉瘤修复患者,EVAR组5742例(76.2%),OAR组1793例(23.8%)。

主要发现

  • IPWR模型中,EVAR组院内死亡OR 0.25(95%CI 0.18-0.34,p<0.001),30天死亡OR 0.31(95%CI 0.23-0.42,p<0.001),MACE OR 0.24(95%CI 0.19-0.31,p<0.001)。
  • Cox模型显示EVAR组1年生存率显著高于OAR(HR 0.61,95%CI 0.50-0.76,p<0.001)。
  • EVAR组其他术后不良事件也少于OAR。

关键数值与推荐

  • EVAR组院内死亡OR 0.25(95%CI 0.18-0.34,p<0.001)。
  • EVAR组30天死亡OR 0.31(95%CI 0.23-0.42,p<0.001)。
  • EVAR组MACE OR 0.24(95%CI 0.19-0.31,p<0.001)。
  • EVAR组1年生存HR 0.61(95%CI 0.50-0.76,p<0.001)。

临床怎么用

  • 解剖适合的累及髂分叉主髂动脉瘤患者,EVAR应作为首选修复方式。
  • 需长期随访比较EVAR与OAR的再干预率和主动脉相关死亡率。

局限性

  • 为回顾性数据库研究,可能存在选择偏倚和未测量混杂。
  • 随访时间较短,长期再干预和主动脉相关死亡率需更长时间研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aneurysmal involvement of the iliac bifurcation increases the complexity of both open and endovascular repair of abdominal aortic aneurysm (AAA), potentially raising the risk of postoperative complications. Randomized trials comparing endovascular aneurysm repair (EVAR) and open aortic repair (OAR) for AAA showed that EVAR is associated with a lower postoperative mortality rate. However, it remains unclear whether these results apply to AAA involving the iliac bifurcation (AAAIB). Several small single-institutional studies have shown conflicting results. This study aims to compare the outcomes of EVAR and OAR for AAAIB in a real-world, multi-institutional setting. METHODS: The Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) database was queried for patients who underwent repair for AAAIB. The cohort was divided into two groups based on the intervention: EVAR vs OAR. Baseline demographic, clinical, and perioperative characteristics, as well as outcomes such as overall 30-day mortality, in-hospital mortality, Major Adverse Cardiovascular Events (MACE: death, myocardial infarction, stroke), intestinal ischemia, overall reinterventions, and 1-year survival, were compared between the groups. Univariable analysis, multivariable inverse probability-weighted regression (IPWR), survival analysis with the Kaplan-Meier method, log-rank test, and Cox proportional hazards regression were performed. RESULTS: Of all reviewed patients, 7,535 were included in the final analysis, of whom 5,742 (76.2%) underwent EVAR, whereas 1,793 (23.8%) underwent OAR. In IPWR models, patients who underwent EVAR had significantly lower odds of overall in-hospital mortality (OR: 0.25, 95%CI: 0.18-0.34, p<0.001), 30-day mortality (OR: 0.31, 95%CI: 0.23-0.42, p<0.001), MACE (OR: 0.24, 95%CI: 0.19-0.31, p<0.001), and other postoperative adverse events compared to OAR. The Cox proportional hazards model demonstrated a significantly higher 1-year survival rate for EVAR compared to OAR (HR: 0.61, 95% CI: 0.50-0.76, p<0.001). CONCLUSIONS: In this real-world, multi-institutional study, EVAR for AAAIB was associated with lower odds of overall in-hospital mortality, 30-day mortality, MACE, as well as a higher 1-year survival rate, compared to the OAR. EVAR should be considered the primary method for repairing aortoiliac aneurysm involving the iliac bifurcation in anatomically suitable patients. Longer follow-up studies are needed to confirm these findings and compare the long-term reintervention and aorta-related mortality rates between the two treatment modalities.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Veranyan N, Kang Sim DE, Ilyas S, et al. Outcomes of Open vs Endovascular Repair of Abdominal Aortic Aneurysm Involving the Iliac Bifurcation. Ann Vasc Surg. 2026. PMID: 42874855. doi:10.1016/j.avsg.2026.09.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。